Pre-treatment of oncolytic reovirus improves tumor accumulation and intratumoral distribution of PEG-liposomes
Journal of Controlled Release · 2023
DOI: 10.1016/j.jconrel.2022.12.050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2023. Verfasst von Maho Eguchi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871,…. Hauptthemen laut MEDLINE: Liposomes, Melanoma, Experimental. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology, Mochida Memorial Foundation for Medical and Pharmaceutical Research.
Abstract (Originalsprache)
PEGylated liposomes (PEG-liposomes) are a promising drug delivery vehicle for tumor targeting because of their efficient tumor disposition profiles via the enhanced permeability and retention (EPR) effect. However, tumor targeting of PEG-liposomes, particularly their delivery inside the tumors, is often disturbed by physical barriers in the tumor, including tumor cells themselves, extracellular matrices, and interstitial pressures. In this study, B16 melanoma tumor-bearing mice were injected intravenously with oncolytic reovirus before administration of PEG-liposomes to enhance PEG-liposomes' tumor disposition. Three days after reovirus administration, significant expression of reovirus sigma 3 protein, elevation of apoptosis-related gene expression, and activation of caspase 3 in the tumors were found. Apoptotic cells were found inside the tumors. These data indicated that reovirus efficiently replicated in the tumors and induced apoptosis of tumor cells. The tumor disposition levels of PEG-liposomes were approximately doubled by reovirus pre-administration, compared with a PBS-pretreated group. PEG-liposomes were widely distributed in the tumors of reovirus-pretreated mice, whereas in the PBS-pretreated group, PEG-liposomes were found mainly around or inside the blood vessels in the tumors. Pre-treatment with reovirus also improved the tumor accumulation of PEG-liposomes in human pancreatic BxPC-3 tumors. 3D imaging analysis of whole BxPC-3 tumors demonstrated that pretreatment with reovirus led to the enhancement of PEG-liposome accumulation inside the tumors. Combination treatment with reovirus and paclitaxel-loaded PEG-liposomes (PTX-PEG-liposomes) significantly suppressed B16 tumor growth. These results provide important information for clinical use of combination therapy of reovirus and nanoparticle-based drug delivery system (DDS).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
- Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan; Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research I…
- Department of Pharmaceutics, Kobe Pharmaceutical University, Kobe 658-8558, Japan.
- Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan; The Center for Advanced Medical Engineering and Informatics, O…
- Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan. Electronic address: sakurai@phs.osaka-u.ac.jp.
Förderung
- Japan Society for the Promotion of Science
- Ministry of Education, Culture, Sports, Science and Technology
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Japan Agency for Medical Research and Development
Zitieren
APA
Eguchi, M., Hirata, S., Ishigami, I., Shuwari, N., Ono, R., Tachibana, M., Tanuma, M., Kasai, A., Hashimoto, H., Ogawara, K. I., Mizuguchi, H., & Sakurai, F. (2023). Pre-treatment of oncolytic reovirus improves tumor accumulation and intratumoral distribution of PEG-liposomes. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2022.12.050
Vancouver
Eguchi M, Hirata S, Ishigami I, Shuwari N, Ono R, Tachibana M, et al. Pre-treatment of oncolytic reovirus improves tumor accumulation and intratumoral distribution of PEG-liposomes. Journal of Controlled Release. 2023. doi:10.1016/j.jconrel.2022.12.050
BibTeX
@article{Eguchi2023,
author = {Eguchi, Maho and Hirata, Seiya and Ishigami, Ikuho and Shuwari, Naomi and Ono, Ryosuke and Tachibana, Masashi and Tanuma, Masato and Kasai, Atsushi and Hashimoto, Hitoshi and Ogawara, Ken-Ichi and Mizuguchi, Hiroyuki and Sakurai, Fuminori},
title = {Pre-treatment of oncolytic reovirus improves tumor accumulation and intratumoral distribution of PEG-liposomes},
journal = {Journal of Controlled Release},
year = {2023},
doi = {10.1016/j.jconrel.2022.12.050}
}
EUVIMED